首页> 外文期刊>Journal of chemical information and modeling >FINDSITEcomb2.0: A New Approach for Virtual Ligand Screening of Proteins and Virtual Target Screening of Biomolecules
【24h】

FINDSITEcomb2.0: A New Approach for Virtual Ligand Screening of Proteins and Virtual Target Screening of Biomolecules

机译:findsitecomb2.0:蛋白质的虚拟配体筛选的新方法和生物分子的虚拟目标筛选

获取原文
获取原文并翻译 | 示例
       

摘要

Computational approaches for predicting protein ligand interactions can facilitate drug lead discovery and drug target determination. We have previously developed a threading/structural-based approach, FINDSITEcomb, for the virtual ligand screening of proteins that has been extensively experimentally validated. Even when low resolution predicted protein structures are employed, FINDSITEcomb has the advantage of being faster and more accurate than traditional high-resolution structure-based docking methods. It also overcomes the limitations of traditional QSAR methods that require a known set of seed ligands that bind to the given protein target. Here, we further improve FINDSITEcomb by enhancing its template ligand selection from the PDB/DrugBank/ChEMBL libraries of known protein ligand interactions by (1) parsing the template proteins and their corresponding binding ligands in the DrugBank and ChEMBL libraries into domains so that the ligands with falsely matched domains to the targets will not be selected as template ligands; (2) applying various thresholds to filter out falsely matched template structures in the structure comparison process and thus their corresponding ligands for template ligand selection. With a sequence identity cutoff of 30% of target to templates and modeled target structures, FINDSITEcomb is shown to significantly improve upon FINDSITEcomb on the DUD-E benchmark set by increasing the 1% enrichment factor from 16.7 to 22.1, with a p-value of 4.3 X 10(-3) by the Student t-test. With an 80% sequence identity cutoff of target to templates for the DUD-E set and modeled target structures, FINDSITEcomb2.0, having a 1% ROC enrichment factor of 52.39, also outperforms state-of-the-art methods that employ machine learning such as a deep convolutional neural network, CNN, with an enrichment of 29.65. Thus, FINDSITEcomb2.0 represents a significant improvement in the state-of-the-art.
机译:预测蛋白质配体相互作用的计算方法可以促进药物铅发现和药物靶标测定。我们以前开发了一种基于螺纹/结构的方法Findsitecomb,用于虚拟配体筛选已广泛进行实验验证的蛋白质。即使在采用低分辨率预测的蛋白质结构,Findsitecomb也具有比传统的高分辨率结构的对接方法更快更准确的优点。它还克服了传统QSAR方法的局限性,所述QSAR方法需要已知的一组与给定的蛋白质靶标结合的种子配体。在这里,通过通过(1)将模板蛋白质及其在药物蛋白中的对应蛋白质和它们的相应结合配体解析到结构域中的域中的PDB /药物库/ Chembl文库中,通过增强其模板配体选择来改善FinceSitecomb由于模板配体,不选择匹配目标的匹配域; (2)在结构比较过程中施加各种阈值以滤除错误匹配的模板结构,因此它们对应于模板配体选择的相应配体。对于模板和建模目标结构的序列同一性截止为占目标和建模的目标结构,所示的FindSitecomb通过增加1%的富集因子从16.7到22.1增加到1%的浓缩因子,P-Vaply 4.3 x 10(-3)由学生t检验。对于DUD-E集合的80%序列同一性截止,对于DUD-E集和建模的目标结构,FindSitecomb2.0,具有1%的ROC浓缩因子为52.39,也优于采用机器学习的最先进方法如深卷积神经网络,CNN,富集为29.65。因此,FindSitecomb2.0表示最先进的显着改善。

著录项

  • 来源
  • 作者单位

    Georgia Inst Technol Sch Biol Sci Ctr Study Syst Biol 950 Atlantic Dr NW Atlanta GA 30332 USA;

    Georgia Inst Technol Sch Biol Sci Ctr Study Syst Biol 950 Atlantic Dr NW Atlanta GA 30332 USA;

    Georgia Inst Technol Sch Biol Sci Ctr Study Syst Biol 950 Atlantic Dr NW Atlanta GA 30332 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 化学;化学工业;
  • 关键词

  • 入库时间 2022-08-20 08:57:04

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号